CJC-1295
Long-acting GHRH analogue
GHRH analogue that prolongs GH/IGF-1 stimulation.
Back to technical sheets- Class
- Long-acting GHRH analogue
- Also known as
- Studied with or without DAC (drug affinity complex); not approved
Mechanism of action
Analogue of growth-hormone-releasing hormone (GHRH). In its DAC form it binds albumin and prolongs its action, sustaining stimulation of the GH/IGF-1 axis.
Evidence
Investigational
Early safety and pharmacokinetic studies; no solid efficacy trials. Not approved. Investigational.
Studied uses
- GH/IGF-1 stimulation (research contexts)
Safety considerations
- Sustained IGF-1 elevation with oncologic precautions
- Limited long-term safety data
- Not approved for human use
Batch quality data
We publish these figures because they are the ones the program itself teaches you to ask for.
- Presentation
- Polvo liofilizado en vial sellado
5 mg Coming soon
Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.